Genie in Bottle: Cellular Bioengineering, Inc.
Biotech Firm Sees Cornea Surgery Success
Five years after setting out to manufacture the delicate tissue that enables the human eye to see clearly, Cellular Bioengineering Inc. has completed 10 successful cornea implants abroad.
The Honolulu biotechnology firm’s patented material for artificial corneas is being manufactured locally and last December was used for eye surgeries in Europe.
Cellular Bioengineering Snags the Nation's Top R&D Honors
Cellular Bioengineering Wins Major R&D Award
Cellular Bioengineering Inc. has received one of R&D magazine's R&D 100 Awards, recognizing the world's best innovations in technology in the past year.
The company won the award for its neural matrix chip that allows for the growth of nerve cells in specific patterns on a microchip.
Founder and CEO Hank Wuh is hoping the R&D award will propel his Honolulu-based company into the big leagues of technology companies and generate worldwide attention from corporate and institutional clients....read more.
A Biotech Firm with its Eyes on the Prize

A Potential Billion Dollar Company
A new Hawaii company hopes to make the blind see.
Cellular Bioengineering Inc., a biotech startup focused on regenerative medicine, has applied for patents on its proprietary bioengineering of replacement parts for aging, diseased or damaged tissues and organs.
The work the company is doing at its nondescript laboratory in Moiliili has the potential to revolutionize the way organs are replaced and create a life-sciences powerhouse in Honolulu.
In many ways, Cellular Bioengineer-ing is a nearly perfect model for those promoting Hawaii's economic diversification. The company could develop its technology anywhere, but chose Hawaii not only because of its proximity to Asian markets but also because half of its employees are kamaaina who received advanced degrees and came home from the Mainland.
"This is a potential billion-dollar annual revenue company," ....read more.
Greater Good Radio Interview
Dr. Hank Wuh has a plan to help millions of blind people to see. Cellular Bioengineering, Inc (CBI) has developed technology to produce corneas to be used in eye transplants. This has been talked about as a multi billion dollar venture with serious social benefit. Dr. Wuh left a promising surgery practice to become a full time inventor and entrepreneur.
Dr. Wuh invented medical devices as a resident at the Stanford University Hospital. He now is an inventor, CEO and investor in the life science field. Hear Dr. Wuh’s unique view of business and how a global mission is the new paradigm.
Some questions asked:
Welcome Hank, can you tell us about the Cellular Bioengineering Inc and what they do?
Does Cellular Bioengineering Inc have a stated business strategy or a “mission statement”?
What’s the story behind Cellular Bioengineering?
What is your role in the company?
Where do you do your science?
Did you ever practice medicine?
How did you become interested in this kind of study?
Congratulations on the award from R&D magazine. The R&D 100 Awards, recognizes the world’s best innovations in technology in the past year. How has the award helped you and your company to further your studies?
How are you able to fund your studies?
What are some of the interesting projects you are working on now?
How do you manage your time?
What do you do to support the community?
What was your experience with venture capitalists?
What do entrepreneurs need to do to raise venture capital?